Low Ferritin with Normal Serum Iron: Evaluation and Management
Low ferritin with normal serum iron indicates depleted iron stores (iron deficiency) even in the absence of anemia, and warrants investigation for underlying causes and consideration of iron supplementation, particularly when ferritin is <30 μg/L in non-inflammatory states. 1
Understanding the Clinical Scenario
This presentation represents early-stage iron deficiency where body iron stores are depleted but hemoglobin production has not yet been significantly affected. 2, 3 The normal serum iron can be misleading, as serum iron has significant diurnal variation and is less reliable than ferritin for assessing iron stores. 4, 2
Diagnostic Interpretation Based on Inflammatory Status
Without Inflammation (CRP normal, no clinical signs)
- Ferritin <15 μg/L: Confirms absolute iron deficiency 1
- Ferritin <30 μg/L: Generally indicates depleted iron stores requiring evaluation 1, 5
- Transferrin saturation <16%: Sensitive marker for iron deficiency, though specificity is only 40-50% 1
With Inflammation Present
The interpretation changes substantially because ferritin is an acute-phase reactant that rises with inflammation, potentially masking true iron deficiency. 1, 6
- Ferritin 30-100 μg/L with transferrin saturation <16%: Likely represents combined iron deficiency and anemia of chronic disease 1
- Ferritin >100 μg/L: The threshold for normal iron stores increases to 100 μg/L in inflammatory states 1
- Always measure inflammatory markers (CRP, ESR) to properly interpret ferritin levels 1
Clinical Evaluation Algorithm
Step 1: Assess for Symptoms and Risk Factors
Even without anemia, iron deficiency can cause: 3, 7
- Fatigue and difficulty concentrating
- Restless legs syndrome (32-40% prevalence)
- Pica (40-50% prevalence)
- Exercise intolerance
- Irritability and depression
Step 2: Identify Underlying Causes
Common causes requiring investigation: 3
- Menstruating women: Heavy or prolonged menstrual bleeding (most common in premenopausal women)
- Gastrointestinal losses: Occult bleeding, inflammatory bowel disease (13-90% have iron deficiency), celiac disease
- Malabsorption: Atrophic gastritis, post-bariatric surgery, celiac disease
- Dietary insufficiency: Vegetarian/vegan diets, eating disorders
- Medications: NSAIDs causing GI blood loss
Step 3: Determine Need for GI Investigation
- GI investigation generally not warranted if ferritin <45 μg/L without GI symptoms and with obvious gynecologic cause
- Consider non-invasive testing for H. pylori and celiac disease first 8
- Bidirectional endoscopy is a conditional recommendation (moderate quality evidence) for asymptomatic premenopausal women 8
For men and postmenopausal women: 5, 8
- Strong recommendation for bidirectional endoscopy when ferritin <45 μg/L (moderate quality evidence) 8
- Higher risk of GI malignancy necessitates investigation 5
For all patients with GI symptoms: 8
- Tailor endoscopic evaluation to symptoms
- Perform non-invasive H. pylori and celiac testing first 8
Treatment Approach
Oral Iron Supplementation (First-Line)
- Ferritin <30 μg/L in healthy individuals
- Ferritin <35 μg/L in athletes 9
- Symptomatic patients with documented iron deficiency
- 100-200 mg elemental iron daily in divided doses, OR
- Alternate-day dosing (better absorption, fewer side effects) 6
- Co-administer with vitamin C to enhance absorption 9
- Avoid tea and coffee around meal times (impair absorption) 9
- Recheck hemoglobin, ferritin, and iron studies after 8-10 weeks 6, 7
- Do not recheck earlier after iron infusion as ferritin will be falsely elevated 6
Intravenous Iron (Specific Indications)
- Oral iron intolerance or gastrointestinal side effects
- Malabsorption (celiac disease, post-bariatric surgery)
- Chronic inflammatory conditions (IBD, CKD, heart failure)
- Ongoing blood loss
- Second and third trimesters of pregnancy 3
- Need for rapid repletion (e.g., preoperative patient blood management) 6
Dosing: 6
- Ferric carboxymaltose: 1000 mg elemental iron infused over 15 minutes
- Multiple formulations available with varying administration schedules
Treatment Targets
- General population: Restore ferritin to >30 μg/L 7
- Athletes: Target >35 μg/L 9
- CKD patients on ESAs: >200 μg/L (but <500-800 μg/L to avoid toxicity) 10
- Normalize hemoglobin if anemia present
- 10-12 g/dL in most clinical contexts 1
Important Caveats
Avoid Iron Supplementation When:
- Ferritin is normal or elevated without documented deficiency 6, 7
- Active infection present (iron can worsen outcomes) 6
- Ferritin >500 μg/L without transferrin saturation <20% (except in specific CKD contexts) 10
Long-Term Management:
- Patients with recurrent iron deficiency benefit from intermittent oral supplementation to maintain stores 7
- Monitor every 6-12 months in at-risk populations 1, 7
- Address underlying causes (treat menorrhagia, manage IBD, etc.) 1